APA (7th ed.) Citation
(2022). Programme death ligand 1 expressions as a surrogate for determining immunotherapy in cervical carcinoma patients.
Chicago Style (17th ed.) Citation
Programme Death Ligand 1 Expressions as a Surrogate for Determining Immunotherapy in Cervical Carcinoma Patients. 2022.
MLA (9th ed.) Citation
Programme Death Ligand 1 Expressions as a Surrogate for Determining Immunotherapy in Cervical Carcinoma Patients. 2022.
Warning: These citations may not always be 100% accurate.